Hyperandrogenic origins of polycystic ovary syndrome – implications for pathophysiology and therapy

References

• Dumesic DA, Oberfield SE, Stener-Victorin E, et al. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015;36(5):487–525.
   PubMed Web of Science ®Google Scholar
• Azziz R, Marin C, Hoq L, et al. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab. 2005;90(8):4650–4658.
   PubMed Web of Science ®Google Scholar
• Azziz R. Polycystic ovary syndrome. Obstet Gynecol. 2018;132(2):321–336.
   PubMed Web of Science ®Google Scholar
• Brakta S, Lizneva D, Mykhalchenko K, et al. Perspectives on polycystic ovary syndrome: is polycystic ovary syndrome research underfunded? J Clin Endocrinol Metab. 2017;102(12):4421–4427.
   PubMed Web of Science ®Google Scholar
• Dokras A, Saini S, Gibson-Helm M, et al. Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome. Fertil Steril. 2017;107(6):1380–1386.e1.
   PubMed Web of Science ®Google Scholar
• International PCOS Network. Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018;110(3):364–379.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.
   Web of Science ®Google Scholar
• Nelson VL, Qin KN, Rosenfield RL, et al. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001;86(12):5925–5933.
   PubMed Web of Science ®Google Scholar
• Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467–520.
   PubMed Web of Science ®Google Scholar
• Ibáñez L, Oberfield SE, Witchel S, et al. An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Horm Res Paediatr. 2017;88(6):371–395.
   PubMed Web of Science ®Google Scholar
• Witchel SF, Oberfield S, Rosenfield RL, et al. The diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr. 2015;83:376–389.
   Web of Science ®Google Scholar
• Abbott DH, Rayome BH, Dumesic DA, et al. Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys. Hum Reprod. 2017;32:923-936.
   PubMed Web of Science ®Google Scholar
• Norman RJ, Dewailly D, Legro RS, et al. Polycystic ovary syndrome. Lancet. 2007;370(9588):685–697.
   PubMed Web of Science ®Google Scholar
• Wild RA, Carmina E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (AE-PCOS) society. J Clin Endocrinol Metab. 2010;95(5):2038–2049.
   PubMed Web of Science ®Google Scholar
• Azziz R, Black V, Hines GA, et al. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab. 1998;83(7):2317–2323.
   PubMed Web of Science ®Google Scholar
• O’Reilly MW, Kempegowda P, Walsh M, et al. AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2017;102(9):3327–3339.
   PubMed Web of Science ®Google Scholar
• Kraynak M, Flowers MT, Shapiro RA, et al. Extraovarian gonadotropin negative feedback revealed by aromatase inhibition in female marmoset monkeys. Am J Physiol Endocrinol Metab. 2017;313(5):E507–E514.
   PubMed Web of Science ®Google Scholar
• O’Reilly MW, Kempegowda P, Jenkinson C, et al. 11-oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome. J Clin Endocrinol Metab. 2017;102(3):840–848.
   PubMed Web of Science ®Google Scholar
• Bobe J, Guiguen Y, Fostier A. Diversity and biological significance of sex hormone-binding globulin in fish, an evolutionary perspective. Mol Cell Endocrinol. 2010;316(1):66–78.
   PubMed Web of Science ®Google Scholar
• Handelsman DJ, Teede HJ, Desai R, et al. Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome. Hum Reprod. 2017;32(2):418–422.
   PubMed Web of Science ®Google Scholar
• McAllister JM, Legro RS, Modi BP, et al. Functional genomics of PCOS: from GWAS to molecular mechanisms. Trends Endocrinol Metab. 2015;26(3):118–124.
   PubMed Web of Science ®Google Scholar
• Dunaif A. Perspectives in polycystic ovary syndrome: from hair to eternity. J Clin Endocrinol Metab. 2016;101(3):759–768.
   PubMed Web of Science ®Google Scholar
• Gorsic LK, Kosova G, Werstein B, et al. Pathogenic Anti-Müllerian hormone variants in polycystic ovary syndrome. J Clin Endocrinol Metab. 2017;102(8):2862–2872.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–284.
   PubMed Web of Science ®Google Scholar
• Crespo RP, Bachega TASS, Mendonça BB, et al. An update of genetic basis of PCOS pathogenesis. Arch Endocrinol Metab. 2018;62(3):352–361.
   PubMed Web of Science ®Google Scholar
• Chen ZJ, Zhao H, He L, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2011;43(1):55–59.
   PubMed Web of Science ®Google Scholar
• Liu H, Zhao H, Chen ZJ. Genome-wide association studies for polycystic ovary syndrome. Semin Reprod Med. 2016;34(4):224–229.
   PubMed Web of Science ®Google Scholar
• Jones MR, Chua AK, Mengesha EA, et al. Metabolic and cardiovascular genes in polycystic ovary syndrome: a candidate-wide association study (CWAS). Steroids. 2012;77(4):317–322.
   PubMed Web of Science ®Google Scholar
• Hayes MG, Urbanek M, Ehrmann DA, et al. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun. 2015;6:7502.
   PubMed Web of Science ®Google Scholar
• Teede HJ, Joham AE, Paul E, et al. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity (Silver Spring). 2013;21(8):1526–1532.
   PubMed Web of Science ®Google Scholar
• Pau CT, Mosbruger T, Saxena R, et al. Phenotype and tissue expression as a function of genetic risk in polycystic ovary syndrome. PLoS One. 2017;12(1):e0168870.
   PubMed Web of Science ®Google Scholar
• Legro RS, Driscoll D, Strauss JF 3rd, et al. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A. 1998;95(25):14956–14960.
   PubMed Web of Science ®Google Scholar
• Vink JM, Sadrzadeh S, Lambalk CB, et al. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab. 2006;91(6):2100–2104.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981–1030.
   PubMed Web of Science ®Google Scholar
• Strauss JF 3rd. Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome. Ann N Y Acad Sci. 2003;997:42–48.
   PubMed Web of Science ®Google Scholar
• Sir-Petermann T, Angel B, Maliqueo M, et al. Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome. Diabetologia. 2002;45(7):959–964.
   PubMed Web of Science ®Google Scholar
• Mahajan A, Taliun D, Thurner M, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet. 2018;50(11):1505-1513.
   Web of Science ®Google Scholar
• Meigs JB, Cupples LA, Wilson PW. Parental transmission of T2D: the framingham offspring study. Diabetes. 2000;49(12):2201–2207.
   PubMed Web of Science ®Google Scholar
• Dabelea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes. 2000;49(12):2208–2211.
   PubMed Web of Science ®Google Scholar
• Barker DJ, Fall CH. Fetal and infant origins of cardiovascular disease. Arch Dis Child. 1993;68(6):797–799.
   PubMed Web of Science ®Google Scholar
• Sommese L, Benincasa G, Lanza M, et al. Novel epigenetic-sensitive clinical challenges both in type 1 and type 2 diabetes. J Diabetes Complications. 2018;32(11):1076–1084.
   PubMed Web of Science ®Google Scholar
• Ortiz-Flores AE, Luque-Ramírez M, Escobar-Morreale HF. Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes. Expert Opin Pharmacother. 2018;5:1–12.
   Google Scholar
• Nugent BM, Bale TL. The omniscient placenta: metabolic and epigenetic regulation of fetal programming. Front Neuroendocrinol. 2015;39:28–37.
   PubMed Web of Science ®Google Scholar
• Corso-Díaz X, Jaeger C, Chaitankar V, et al. Epigenetic control of gene regulation during development and disease: A view from the retina. Prog Retin Eye Res. 2018;65:1–27.
   PubMed Web of Science ®Google Scholar
• Moore GE, Abu-Amero SN, Bell G, et al. Evidence that insulin is imprinted in the human yolk sac. Diabetes. 2001;50(1):199–203.
   PubMed Web of Science ®Google Scholar
• Li S, Zhu D, Duan H, et al. The epigenomics of polycystic ovarian syndrome: from pathogenesis to clinical manifestations. Gynecol Endocrinol. 2016;32(12):942–946.
   PubMed Web of Science ®Google Scholar
• Lambertini L, Saul SR, Copperman AB, et al. Intrauterine reprogramming of the polycystic ovary syndrome: evidence from a pilot study of cord blood global methylation analysis. Front Endocrinol (Lausanne). 2017;8:352.
   PubMed Web of Science ®Google Scholar
• Wang P, Zhao H, Li T, et al. Hypomethylation of the LH/choriogonadotropin receptor promoter region is a potential mechanism underlying susceptibility to polycystic ovary syndrome. Endocrinology. 2014;155(4):1445–1452.
   PubMed Web of Science ®Google Scholar
• Jones MR, Brower MA, Xu N, et al. Systems genetics reveals the functional context of PCOS loci and identifies genetic and molecular mechanisms of disease heterogeneity. PLoS Genet. 2015;11(8):e1005455.
   PubMed Web of Science ®Google Scholar
• Song J, Luo S, Li SW. miRNA-592 is downregulated and may target LHCGR in polycystic ovary syndrome patients. Reprod Biol. 2015;15(4):229–237.
   PubMed Web of Science ®Google Scholar
• Comim FV, Teerds K, Hardy K, et al. Increased protein expression of LHCG receptor and 17α-hydroxylase/17–20-lyase in human polycystic ovaries. Hum Reprod. 2013;28(11):3086–3092.
   PubMed Web of Science ®Google Scholar
• Hirshfeld-Cytron J, Barnes RB, Ehrmann DA, et al. Characterization of functionally typical and atypical types of polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94(5):1587–1594.
   PubMed Web of Science ®Google Scholar
• Wang XX, Wei JZ, Jiao J, et al. Genome-wide DNA methylation and gene expression patterns provide insight into polycystic ovary syndrome development. Oncotarget. 2014;5(16):6603–6610.
   PubMedGoogle Scholar
• Yu YY, Sun CX, Liu YK, et al. Genome-wide screen of ovary-specific DNA methylation in polycystic ovary syndrome. Fertil Steril. 2015;104(1):145–153.e6.
   PubMed Web of Science ®Google Scholar
• Jiang SW, Xu S, Chen H, et al. Pathologic significance of SET/I2PP2A-mediated PP2A and non-PP2A pathways in Polycystic Ovary Syndrome (PCOS). Clin Chim Acta. 2017;464:155-159.
   PubMed Web of Science ®Google Scholar
• Xu B, Gao L, Cui Y, et al. SET protein up-regulated testosterone production in the cultured preantral follicles. Reprod Biol Endocrinol. 2013;11:9.
   PubMed Web of Science ®Google Scholar
• Murri M, Insenser M, Fernández-Durán E, et al. Non-targeted profiling of circulating microRNAs in women with polycystic ovary syndrome (PCOS): effects of obesity and sex hormones. Metabolism. 2018;86:49.
   PubMed Web of Science ®Google Scholar
• Beck-Peccoz P, Padmanabhan V, Baggiani AM, et al. Maturation of hypothalamic-pituitary-gonadal function in normal human fetuses: circulating levels of gonadotropins, their common alpha-subunit and free testosterone, and discrepancy between immunological and biological activities of circulating follicle-stimulating hormone. J Clin Endocrinol Metab. 1991;73(3):525–532.
   PubMed Web of Science ®Google Scholar
• Palomba S, Marotta R, Di Cello A, et al. Pervasive developmental disorders in children of hyperandrogenic women with polycystic ovary syndrome: a longitudinal case-control study. Clin Endocrinol (Oxf). 2012;77(6):898–904.
   PubMed Web of Science ®Google Scholar
• Schindler AE. Hormones in human amniotic fluid. Monogr Endocrinol. 1982;21:1–158.
   PubMedGoogle Scholar
• Goy RW, Bercovitch FB, McBrair MC. Behavioral masculinization is independent of genital masculinization in prenatally androgenized female rhesus macaques. Horm Behav. 1988;22(4):552–571.
   PubMed Web of Science ®Google Scholar
• Roselli CE, Estill CT, Stadelman HL, et al. Separate critical periods exist for testosterone-induced differentiation of the brain and genitals in sheep. Endocrinology. 2011;152(6):2409–2415.
   PubMed Web of Science ®Google Scholar
• Dean A, Sharpe RM. Clinical review: anogenital distance or digit length ratio as measures of fetal androgen exposure: relationship to male reproductive development and its disorders. J Clin Endocrinol Metab. 2013;98(6):2230–2238.
   PubMed Web of Science ®Google Scholar
• Abbott DH, Barnett DK, Levine JE, et al. Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys. Biol Reprod. 2008;79(1):154–163.
   PubMed Web of Science ®Google Scholar
• Veiga-Lopez A, Steckler TL, Abbott DH, et al. Developmental programming: impact of excess prenatal testosterone on intrauterine fetal endocrine milieu and growth in sheep. Biol Reprod. 2011;84(1):87–96.
   PubMed Web of Science ®Google Scholar
• Abbott DH, Levine JE, Dumesic DA. Translational insight into Polycystic Ovary Syndrome (PCOS) from female monkeys with PCOS-like traits. Curr Pharm Des. 2016;22(36):5625–5633.
   PubMed Web of Science ®Google Scholar
• Cesta CE, Månsson M, Palm C, et al. Polycystic ovary syndrome and psychiatric disorders: co-morbidity and heritability in a nationwide Swedish cohort. Psychoneuroendocrinology. 2016;73:196–203.
   PubMed Web of Science ®Google Scholar
• Sir-Petermann T, Maliqueo M, Angel B, et al. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod. 2002;17(10):2573–2579.
   PubMed Web of Science ®Google Scholar
• Weiss PAM, Scholz HS, Haas J, et al. Long-term follow-up of diabetes of mothers with type I diabetes. Evidence for hereditary and nonhereditary transmission of diabetes and precursors. Diabetes Care. 2000;23:905-911  .
   Web of Science ®Google Scholar
• Maliqueo M, Lara HE, Sánchez F, et al. Placental steroidogenesis in pregnant women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2013;166(2):151–155.
   PubMed Web of Science ®Google Scholar
• Fux-Otta C, Maliqueo M, Echiburú B, et al. Pregnancy outcomes in women with polycystic ovary syndrome in two Latin American populations. J Obstet Gynaecol. 2018;38(6):750–755.
   PubMedGoogle Scholar
• Palm CVB, Glintborg D, Kyhl HB, et al. Polycystic ovary syndrome and hyperglycaemia in pregnancy. A narrative review and results from a prospective Danish cohort study. Diabetes Res Clin Pract. 2018;145:167-177.
   PubMed Web of Science ®Google Scholar
• Bahri Khomami M, Boyle JA, Tay CT, et al. Polycystic ovary syndrome and adverse pregnancy outcomes: current state of knowledge, challenges and potential implications for practice. Clin Endocrinol (Oxf). 2018;88(6):761-769.
   PubMed Web of Science ®Google Scholar
• Tata B, Mimouni NEH, Barbotin AL, et al. Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat Med. 2018;24(6):834–846.
   PubMed Web of Science ®Google Scholar
• Homburg R, Gudi A, Shah A, et al. A novel method to demonstrate that pregnant women with polycystic ovary syndrome hyper-expose their fetus to androgens as a possible stepping stone for the developmental theory of PCOS. A pilot study. Reprod Biol Endocrinol. 2017;15:61.
   PubMed Web of Science ®Google Scholar
• Giacomoni PU, Mammone T, Teri M. Gender-linked differences in human skin. J Dermatol Sci. 2009;55:144–149.
   PubMed Web of Science ®Google Scholar
• Barrett ES, Hoeger KM, Sathyanarayana S, et al. Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure. J Dev Orig Health Dis. 2018 Jan;9:1–8.
   Web of Science ®Google Scholar
• Abbott AD, Colman RJ, Tiefenthaler R, et al. Early-to-mid gestation fetal testosterone increases right hand 2D:4D finger length ratio in polycystic ovary syndrome-like monkeys. PLoS One. 2012;7(8):e42372.
   PubMed Web of Science ®Google Scholar
• Sir-Petermann T, Codner E, Maliqueo M, et al. Increased anti-Müllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(8):3105–3109.
   PubMed Web of Science ®Google Scholar
• Sánchez-Ferrer ML, Mendiola J, Hernández-Peñalver AI, et al. Presence of polycystic ovary syndrome is associated with longer anogenital distance in adult Mediterranean women. Hum Reprod. 2017;32:2315-2323.
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhong G, Chen S, et al. Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure. Hum Reprod. 2017;32:937-943.
   PubMed Web of Science ®Google Scholar
• Hernández-Peñalver AI, Sánchez-Ferrer ML, Mendiola J, et al. Assessment of anogenital distance as a diagnostic tool in polycystic ovary syndrome. Reprod Biomed Online. 2018;37(6):741-749.
   PubMed Web of Science ®Google Scholar
• Lujan ME, Bloski TG, Chizen DR, et al. Digit ratios do not serve as anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome. Hum Reprod. 2010;25:204-211.
   Web of Science ®Google Scholar
• Torchen LC, Idkowiak J, Fogel NR, et al. Evidence for increased 5α-reductase activity during early childhood in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2016;101:2069-2075.
   Web of Science ®Google Scholar
• Barry JA, Kay AR, Navaratnarajah R, et al. Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels. J Obstet Gynaecol. 2010;30:444-446.
   Google Scholar
• Daan NM, Koster MP, Steegers-Theunissen RP, et al. Endocrine and cardiometabolic cord blood characteristics of offspring born to mothers with and without polycystic ovary syndrome. Fertil Steril. 2017;107:261-268.e3.
   PubMed Web of Science ®Google Scholar
• Caanen MR, Kuijper EA, Hompes PG, et al. Mass spectrometry methods measured androgen and estrogen concentrations during pregnancy and in newborns of mothers with polycystic ovary syndrome. Eur J Endocrinol. 2016;174:25-32.
   PubMed Web of Science ®Google Scholar
• Anderson H, Fogel N, Grebe SK, et al. Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels. J Clin Endocrinol Metab. 2010;95:2180-2186.
   Web of Science ®Google Scholar
• Hollier LP, Keelan JA, Hickey M, et al. Measurement of androgen and estrogen concentrations in cord blood: accuracy, biological interpretation, and applications to understanding human behavioral development. Front Endocrinol (Lausanne). 2014;5:64.
   PubMed Web of Science ®Google Scholar
• Abbott DH, Dumesic DA, Eisner JR, et al. Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys. Trends Endocrinol Metab. 1998;9(2):62-67.
   Web of Science ®Google Scholar
• Eisner JR, Dumesic DA, Kemnitz JW, et al. Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys. J Clin Endocrinol Metab. 2000;85(3):1206-1210.
   Web of Science ®Google Scholar
• Abbott DH, Tarantal AF, Dumesic DA. Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys. Am J Primatol. 2009;71(9):776-784.
   Web of Science ®Google Scholar
• Herman RA, Jones B, Mann DR, et al. Timing of prenatal androgen exposure: anatomical and endocrine effects on juvenile male and female rhesus monkeys. Horm Behav. 2000;38(1):52-66.
   PubMed Web of Science ®Google Scholar
• Pepe GJ, Maniu A, Aberdeen G, et al. Insulin resistance elicited in postpubertal primate offspring deprived of estrogen in utero. Endocrine. 2016;54(3):788–797.
   PubMed Web of Science ®Google Scholar
• Pepe GJ, Lynch TJ, Albrecht ED. Regulation of baboon fetal ovarian development by placental estrogen: onset of puberty is delayed in offspring deprived ofestrogen in utero. Biol Reprod. 2013;89(6):132.
   PubMed Web of Science ®Google Scholar
• Kim SO, Aberdeen G, Lynch TJ, et al. Adipose and liver function in primate offspring with insulin resistance induced by estrogen deprivation in utero. Endocrinol Diabetes Metab J. 2017;1(3).
   Google Scholar
• Pepe GJ, Maniu A, Aberdeen G, et al. Estrogen regulation of fetal adrenal cortical zone-specific development in the nonhuman primate impacts adrenal production of androgen and cortisol and response to ACTH in females in adulthood. Endocrinology. 2016;157(5):1905-1913.
   Web of Science ®Google Scholar
• Clarke IJ, Scaramuzzi RJ, Short RV. Ovulation in prenatally androgenized ewes. J Endocrinol. 1977;73(2):385-389.
   Web of Science ®Google Scholar
• Veiga-Lopez A, Moeller J, Patel D, et al. Developmental programming: impact of prenatal testosterone excess on insulin sensitivity, adiposity, and free fatty acid profile in postpubertal female sheep. Endocrinology. 2013;154(5):1731-1742.
   Web of Science ®Google Scholar
• Robinson JE, Forsdike RA, Taylor JA. In utero exposure of female lambs to testosterone reduces the sensitivity of the gonadotropin-releasing hormone neuronal network to inhibition by progesterone. Endocrinology. 1999;140(12):5797-5805.
   Web of Science ®Google Scholar
• Recabarren SE, Padmanabhan V, Codner E, et al. Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone. Am J Physiol Endocrinol Metab. 2005;289(5):E801-E806.
   Web of Science ®Google Scholar
• Smith P, Steckler TL, Veiga-Lopez A, et al. Developmental programming: differential effects of prenatal testosterone and dihydrotestosterone on follicular recruitment, depletion of follicular reserve, and ovarian morphology in sheep. Biol Reprod. 2009;80(4):726-736.
   Web of Science ®Google Scholar
• Padmanabhan V, Veiga-Lopez A. Sheep models of polycystic ovary syndrome phenotype. Mol Cell Endocrinol. 2013;373(1–2):8-20.
   PubMed Web of Science ®Google Scholar
• Abi Salloum B, Herkimer C, Lee JS, et al. Developmental programming: prenatal and postnatal contribution of androgens and insulin in the reprogramming of estradiol positive feedback disruptions in prenatal testosterone-treated sheep. Endocrinology. 2012;153(6):2813-2822.
   Web of Science ®Google Scholar
• Veiga-Lopez A, Lee JS, Padmanabhan V. Developmental programming: insulin sensitizer treatment improves reproductive function in prenatal testosterone-treated female sheep. Endocrinology. 2010;151(8):4007-4017.
   Web of Science ®Google Scholar
• Abi Salloum B, Veiga-Lopez A, Abbott DH, et al. Developmental programming: exposure to testosterone excess disrupts steroidal and metabolic environment in pregnant sheep. Endocrinology. 2015 Jun;156(6):2323-2337.
   Web of Science ®Google Scholar
• Rae M, Grace C, Hogg K, et al. The pancreas is altered by in utero androgen exposure: implications for clinical conditions such as polycystic ovary syndrome (PCOS). PLoS One. 2013;8(2):e56263.
   PubMed Web of Science ®Google Scholar
• Hogg K, Wood C, McNeilly AS, et al. The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep. PLoS One. 2011;6(9):e24877.
   PubMed Web of Science ®Google Scholar
• Ramaswamy S, Grace C, Mattei AA, et al. Developmental programming of polycystic ovary syndrome (PCOS): prenatal androgens establish pancreatic islet α/β cell ratio and subsequent insulin secretion. Sci Rep. 2016;6:27408.
   PubMed Web of Science ®Google Scholar
• Wu XY, Li ZL, Wu CY, et al. Endocrine traits of polycystic ovary syndrome in prenatally androgenized female Sprague-Dawley rats. Endocr J. 2010;57(3):201-209.
   Web of Science ®Google Scholar
• Slob AK, Den Hamer R, Woutersen PJ, et al. Prenatal testosterone propionate and postnatal ovarian activity in the rat. Acta Endocrinol (Copenh). 1983;103(3):420-427.
   Google Scholar
• Demissie M, Lazic M, Foecking EM, et al. Transient prenatal androgen exposure produces metabolic syndrome in adult female rats. Am J Physiol Endocrinol Metab. 2008;295(2):E262-E268.
   Web of Science ®Google Scholar
• Foecking EM, McDevitt MA, Acosta-Martínez M, et al. Neuroendocrine consequences of androgen excess in female rodents. Horm Behav. 2008;53(5):673-692.
   Web of Science ®Google Scholar
• Fagman JB, Wilhelmson AS, Motta BM, et al. The androgen receptor confers protection against diet-induced atherosclerosis, obesity, and dyslipidemia in female mice. FASEB J. 2015;29(4):1540-1550.
   Web of Science ®Google Scholar
• Walters KA, Edwards MC, Tesic D, et al. The role of central androgen receptor actions in regulating the hypothalamic-pituitary-ovarian axis. Neuroendocrinology. 2018;106(4):389-400.
   PubMed Web of Science ®Google Scholar
• Van Sinderen M, Steinberg G, Jorgensen SB, et al. Sexual dimorphism in the glucose homeostasis phenotype of the aromatase knockout (ArKO) mice. J Steroid Biochem Mol Biol. 2017;170:39-48.
   PubMed Web of Science ®Google Scholar
• Schomberg DW, Couse JF, Mukherjee A, et al. Targeted disruption of the estrogen receptor-alpha gene in female mice: characterization of ovarian responses and phenotype in the adult. Endocrinology. 1999;140(6):2733-2744.
   Web of Science ®Google Scholar
• Park CJ, Zhao Z, Glidewell-Kenney C, et al. Genetic rescue of nonclassical ERα signaling normalizes energy balance in obese Erα-null mutant mice. J Clin Invest. 2011;121(2):604-612.
   Web of Science ®Google Scholar
• Risma KA, Clay CM, Nett TM, et al. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc Natl Acad Sci U S A. 1995;92(5):1322-1326.
   Web of Science ®Google Scholar
• Nilson JH, Abbud RA, Keri RA, et al. Chronic hypersecretion of luteinizing hormone in transgenic mice disrupts both ovarian and pituitary function, with some effects modified by the genetic background. Recent Prog Horm Res. 2000;55:69-89.
   Google Scholar
• Kero JT, Savontaus E, Mikola M, et al. Obesity in transgenic female mice with constitutively elevated luteinizing hormone secretion. Am J Physiol Endocrinol Metab. 2003;285(4):E812-E818.
   Web of Science ®Google Scholar
• Abbott DH, Bruns CR, Barnett DK, et al. Experimentally induced gestational androgen excess disrupts glucoregulation in rhesus monkey dams and their female offspring. Am J Physiol Endocrinol Metab. 2010;299(5):E741-E751.
   Web of Science ®Google Scholar
• Sullivan EL, Rivera HM, True CA, et al. Maternal and postnatal high-fat diet consumption programs energy balance and hypothalamic melanocortin signaling in nonhuman primate offspring. Am J Physiol Regul Integr Comp Physiol. 2017;313:R169-R179.
   PubMed Web of Science ®Google Scholar
• Nicol LE, O’Brien TD, Dumesic DA, et al. Abnormal infant islet morphology precedes insulin resistance in PCOS-like monkeys. PLoS One. 2014;9:e106527.
   PubMed Web of Science ®Google Scholar
• Martin B, Sacks DA. The global burden of hyperglycemia in pregnancy – trends from studies in the last decade. Diabetes Res Clin Pract. 2018;145:17-19.
   Web of Science ®Google Scholar
• Goy RW, Robinson JA. Prenatal exposure of rhesus monkeys to patent androgens: morphological, behavioral and physiological consequences. In: Hunt VR, Smith MK, Worth D, editors. Banbury report II: environmental factors in human growth and development. Cold Spring Harbor: Cold Spring Harbor Laboratory; 1982. p. 355–378.
   Google Scholar
• Zehr JL, Van Meter PE, Wallen K. Factors regulating the timing of puberty onset in female rhesus monkeys (Macaca mulatta): role of prenatal androgens, social rank, and adolescent body weight. Biol Reprod. 2005;72:1087-1094.
   Web of Science ®Google Scholar
• Abbott DH, Nicol LE, Levine JE, et al. Nonhuman primate models of polycystic ovary syndrome. Mol Cell Endocrinol. 2013;373(1–2):21-28.
   Web of Science ®Google Scholar
• Abbott DH, Dumesic DA, Eisner JR, et al. The prenatally androgenized female rhesus monkey as a model for polycystic ovarian syndrome. In: Azziz R, Nestler JE, Dewailly D, editors. Androgen excess disorders in women. Philadelphia: Lippencott-Raven Press; 1997. p. 369–382.
   Google Scholar
• Abbott DH, Vepraskas SH, Horton TH, et al. Accelerated episodic luteinizing hormone release accompanies blunted progesterone regulation in PCOS-like female rhesus monkeys (Macaca Mulatta) exposed to testosterone during early-to-mid gestation. Neuroendocrinology. 2018;107(2):133–146.
   PubMed Web of Science ®Google Scholar
• Daniels TL, Berga SL. Resistance of gonadotropin releasing hormone drive to sex steroid-induced suppression in hyperandrogenic anovulation. J Clin Endocrinol Metab. 1997;82;4179-4183.
   Web of Science ®Google Scholar
• Eagleson CA, Gingrich MB, Pastor CL, et al. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab. 2000;85:4047-4052.
   Web of Science ®Google Scholar
• Dumesic DA, Schramm RD, Peterson E, et al. Impaired developmental competence of oocytes in adult prenatally androgenized female rhesus monkeys undergoing gonadotropin stimulation for in vitro fertilization. J Clin Endocrinol Metab. 2002;87:1111-1119.
   Web of Science ®Google Scholar
• Broughton DE, Moley KH. Obesity and female infertility: potential mediators of obesity’s impact. Fertil Steril. 2017;107:840-847.
   PubMed Web of Science ®Google Scholar
• Dumesic DA, Patankar MS, Barnett DK, et al. Early prenatal androgenization results in diminished ovarian reserve in adult female rhesus monkeys. Hum Reprod. 2009;24:3188-3195.
   Web of Science ®Google Scholar
• Ahmad AK, Kao CN, Quinn M, et al. Differential rate in decline in ovarian reserve markers in women with polycystic ovary syndrome compared with control subjects: results of a longitudinal study. Fertil Steril. 2018;109:526-531.
   PubMed Web of Science ®Google Scholar
• Abbott DH, Barnett DK, Bruns CM, et al. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update. 2005;11(4):357-374.
   Web of Science ®Google Scholar
• Lee S, Arslanian S. Body composition and cardiorespiratory fitness between metabolically healthy versus metabolically unhealthy obese black and white adolescents. J Adolesc Health. 2018 Oct 31;S1054–S139X(18): 30408–7. DOI:10.1016/j.jadohealth.2018.08.024. [Epub ahead of print].
   Google Scholar
• Keller E, Chazenbalk GD, Aguilera P, et al. Impaired preadipocyte differentiation into adipocytes in subcutaneous abdominal adipose of PCOS-like female rhesus monkeys. Endocrinology. 2014;155:2696-2703.
   Web of Science ®Google Scholar
• Xu N, Kwon S, Abbott DH, et al. Epigenetic mechanism underlying the development of polycystic ovary syndrome(PCOS)-like phenotypes in prenatally androgenized rhesus monkeys. PLoS One. 2011;6:e27286.
   PubMed Web of Science ®Google Scholar
• Pervin S, Singh V, Tucker A, et al. Modulation of transforming growth factor-β/follistatin signaling and white adipose browning: therapeutic implications for obesity related disorders. Horm Mol Biol Clin Investig. 2017;31(2).
   Web of Science ®Google Scholar
• Sam S. Differential effect of subcutaneous abdominal and visceral adipose tissue on cardiometabolic risk. Horm Mol Biol Clin Investig. 2018;33(1).
   Web of Science ®Google Scholar
• Zhou R, Bruns CM, Bird IM, et al. Pioglitazone improves insulin action and normalizes menstrual cycles in a majority of prenatally androgenized female rhesus monkeys. Reprod Toxicol. 2007;23:438-448.
   Web of Science ®Google Scholar
• Padmanabhan V, Cardoso RC, Puttabyatappa M. Developmental programming, a pathway to disease. Endocrinology. 2016;157:1328-1340.
   Web of Science ®Google Scholar
• Moore AM, Campbell RE. Polycystic ovary syndrome: understanding the role of the brain. Front Neuroendocrinol. 2017;46:1-14.
   PubMed Web of Science ®Google Scholar
• Walters KA, Gilchrist RB, Ledger WL, et al. New perspectives on the pathogenesis of PCOS: neuroendocrine origins. Trends Endocrinol Metab. 2018;29(12):841-852.
   PubMed Web of Science ®Google Scholar
• Hogg K, Young JM, Oliver EM, et al. Enhanced thecal androgen production is prenatally programmed in an ovine model of polycystic ovary syndrome. Endocrinology. 2012;153:450-461.
   Web of Science ®Google Scholar
• Ortega HH, Salvetti NR, Padmanabhan V. Developmental programming: prenatal androgen excess disrupts ovarian steroid receptor balance. Reproduction. 2009;137:865-877.
   Web of Science ®Google Scholar
• Veiga-Lopez A, Moeller J, Abbott DH, et al. Developmental programming: rescuing disruptions in preovulatory follicle growth and steroidogenesis from prenatal testosterone disruption. J Ovarian Res. 2016;9(1):39.
   Web of Science ®Google Scholar
• Padmanabhan V, Veiga-Lopez A, Herkimer C, et al. Developmental programming: prenatal and postnatal androgen antagonist and insulin sensitizer interventions prevent advancement of puberty and improve LH surge dynamics in prenatal testosterone-treated sheep. Endocrinology. 2015;156(7):2678-2692.
   Web of Science ®Google Scholar
• Roland AV, Nunemaker CS, Keller SR, et al. Prenatal androgen exposure programs metabolic dysfunction in female mice. J Endocrinol. 2010;207(2):213-223.
   Web of Science ®Google Scholar
• De Leo V, Lanzetta D, D’Antona D, et al. Hormonal effects of flutamide in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998;83;99-102.
   PubMed Web of Science ®Google Scholar
• Caldwell AS, Eid S, Kay CR, et al. Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization. Endocrinology. 2015;156(4):1441-1452.
   Web of Science ®Google Scholar
• Caldwell ASL, Edwards MC, Desai R, et al. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome. Proc Natl Acad Sci U S A. 2017;114:E3334-E3343.
   PubMed Web of Science ®Google Scholar
• Silva MS, Prescott M, Campbell RE. Ontogeny and reversal of brain circuit abnormalities in a preclinical model of PCOS. JCI Insight. 2018;3(7).
   Web of Science ®Google Scholar
• Moore AM, Prescott M, Marshall CJ, et al. Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome. Proc Natl Acad Sci U S A. 2015;112:596-601.
   PubMed Web of Science ®Google Scholar
• Sullivan SD, Moenter SM. Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder. Proc Natl Acad Sci U S A. 2004;101:7129-7134.
   Web of Science ®Google Scholar
• Dunaif A, Chang RJ, Franks S, et al. Polycystic ovary syndrome: current controversies, from the ovary to the pancreas. Totowa, NJ: Humana Press; 2008.  p. vii.
   Google Scholar
• Tomaszycki ML, Gouzoules H, Wallen K. Sex differences in juvenile rhesus macaque (Macaca mulatta) agonistic screams: life history differences and effects of prenatal androgens. Dev Psychobiol. 2005;47(4):318–327.
   PubMed Web of Science ®Google Scholar
• Herman RA, Wallen K. Cognitive performance in rhesus monkeys varies by sex and prenatal androgen exposure. Horm Behav. 2007;51(4):496–507.
   PubMed Web of Science ®Google Scholar
• Wallen K. Hormonal influences on sexually differentiated behavior in nonhuman primates. Front Neuroendocrinol. 2005;26(1):7–26.
   PubMed Web of Science ®Google Scholar
• Cardoso RC, Burns A, Moeller J, et al. Developmental programming: insulin sensitizer prevents the GnRH-stimulated LH hypersecretion in a sheep model of PCOS. Endocrinology. 2016;157:4641-4653.
   PubMed Web of Science ®Google Scholar
• Holt RI, Lambert KD. The use of oral hypoglycaemic agents in pregnancy. Diabet Med. 2014;31(3):282–291.
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Pranikoff J, Aregawi D, et al. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome. Fertil Steril. 2008;89(3):625–634.
   PubMed Web of Science ®Google Scholar
• Hjorth-Hansen A, Salvesen Ø, Engen Hanem LG, et al. Fetal growth and birth anthropometrics in metformin-exposed offspring born to mothers with PCOS. J Clin Endocrinol Metab. 2018;103(2):740–747.
   PubMed Web of Science ®Google Scholar
• Hanem LGE, Stridsklev S, Júlíusson PB, et al. Metformin use in PCOS pregnancies increases the risk of offspring overweight at 4 years of age: follow-up of two RCTs. J Clin Endocrinol Metab. 2018;103(4):1612–1621.
   PubMed Web of Science ®Google Scholar
• Barbour LA, Scifres C, Valent AM, et al. A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes. Am J Obstet Gynecol. 2018;219(4):367.e1–367.e7.
   PubMed Web of Science ®Google Scholar
• Løvvik TS, Carlsen SM, Steffensen B, et al. Metformin treatment of pregnant women with polycystic ovary syndrome - a randomized, nordic multi-center trial. OR33-4. Endocr Rev. 2018;38(2,Suppl):OR33–4.
   Google Scholar
• Biondani G, Peyron JF. Metformin, an Anti-diabetic Drug to Target Leukemia. Front Endocrinol (Lausanne). 2018;9:446.
   PubMed Web of Science ®Google Scholar
• de Zegher F, Lopez-Bermejo A, Ibáñez L. Adipose tissue expandability and the early origins of PCOS. Trends Endocrinol Metab. 2009;20(9):418–423.
   PubMed Web of Science ®Google Scholar
• Dumesic DA, Akopians AL, Madrigal VK, et al. Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women. J Clin Endocrinol Metab. 2016;101(11):4178–4188.
   PubMed Web of Science ®Google Scholar
• Harnois-Leblanc S, Trottier A, Leblanc S, et al. Evolution of metabolic alterations 5 Years after early puberty in a cohort of girls predisposed to polycystic ovary syndrome. Reprod Biol Endocrinol. 2017;15(1):56.
   PubMedGoogle Scholar
• Han SY, Clarkson J, Piet R, et al. Optical approaches for interrogating neural circuits controlling hormone secretion. Endocrinology. 2018;159(11):3822–3833.
   PubMed Web of Science ®Google Scholar
• Levine JE, Kraynak M, Willging MM, et al. Hypothalamic ERa gene silencing induces obesity in female Rhesus monkeys. Endocr Rev. 2018;39(2): Suppl: SUN-072.
   Google Scholar
• Seita Y, Tsukiyama T, Iwatani C, et al. Generation of transgenic cynomolgus monkeys that express green fluorescent protein throughout the whole body. Sci Rep. 2016;6:24868.
   PubMed Web of Science ®Google Scholar